On Monday, May 25, the next meeting of the AOTMiT Transparency Council.
AOTMiT: AOTMiT Transparency Council on COPD, myasthenia gravis and pertussis, among others
Published May 22, 2026 07:23
Źródło: AOTMiT
The agenda includes:
- Preparation of a position on the qualification of the health care service District Health Center.
- Preparation of a position paper on the evaluation of the drug Dupixent (dupilumabum) under the drug program "Treatment of patients with chronic obstructive pulmonary disease (COPD) (ICD-10: J44)".
- Preparation of a position paper on the evaluation of the drug Zilbrysq (zilucoplanum) under the drug program B.157. "Treatment of patients with generalized form of myasthenia gravis (G.70.0)".
- Preparation of an opinion on the draft health policy program of the local government unit "Program in the field of vaccination against pertussis in the municipality of Ozarow Mazowiecki for the year 2026"
- Preparation of an opinion on the draft health policy program of the local government unit "Early specialized and comprehensive care for a child at risk of disability or with disabilities from the Municipality of Nędza".
Source: AOTMiT
